TRANSENTERIX INC's ticker is TRXC and the CUSIP is 89366M201. A total of 153 filers reported holding TRANSENTERIX INC in Q4 2018. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $110,000 | -36.0% | 80,625 | +11.6% | 0.00% | -50.0% |
| Q1 2019 | $172,000 | +5.5% | 72,225 | 0.0% | 0.00% | -33.3% |
| Q4 2018 | $163,000 | -59.9% | 72,225 | +3.2% | 0.00% | -70.0% |
| Q3 2018 | $406,000 | +33.1% | 70,000 | 0.0% | 0.01% | +11.1% |
| Q2 2018 | $305,000 | +125.9% | 70,000 | 0.0% | 0.01% | +80.0% |
| Q4 2017 | $135,000 | +35.0% | 70,000 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $100,000 | +100.0% | 70,000 | 0.0% | 0.01% | +150.0% |
| Q2 2017 | $50,000 | +108.3% | 70,000 | +250.0% | 0.00% | +100.0% |
| Q1 2017 | $24,000 | -7.7% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $26,000 | -23.5% | 20,000 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $34,000 | +41.7% | 20,000 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $24,000 | -71.8% | 20,000 | 0.0% | 0.00% | -80.0% |
| Q1 2016 | $85,000 | +70.0% | 20,000 | 0.0% | 0.01% | +66.7% |
| Q4 2015 | $50,000 | +11.1% | 20,000 | 0.0% | 0.00% | +50.0% |
| Q3 2015 | $45,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 7,546,692 | $10,792,000 | 8.18% |
| StepStone Group LP | 3,032,625 | $4,336,000 | 2.87% |
| Aisling Capital LLC | 10,335,819 | $14,780,000 | 2.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 889,082 | $1,271,000 | 0.50% |
| ELEMENT CAPITAL MANAGEMENT LLC | 249,959 | $357,000 | 0.15% |
| MASTERS CAPITAL MANAGEMENT LLC | 4,000,000 | $5,720,000 | 0.13% |
| BRANDYWINE MANAGERS, LLC | 49,000 | $70,000 | 0.02% |
| NATIONAL PLANNING CORP | 159,250 | $228,000 | 0.02% |
| Jacobi Capital Management LLC | 30,000 | $45,000 | 0.02% |
| AE Wealth Management LLC | 106,010 | $152,000 | 0.01% |